Progesterone use in assisted reproductive technology.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Grupos

Abstract

Progesterone is the main hormone in the luteal phase. It plays a key role in preparing the uterus for a possible pregnancy, and in maintaining it after it has occurred. In assisted reproduction treatments, there is usually a luteal phase deficiency, so it is necessary to supplement this critical phase to obtain the best results, not only of implantation but also of ongoing pregnancy. Among all the available options, exogenously administered progestogens are the most used, as they have proven their efficacy and safety. This review will address the most relevant aspects of luteal phase support with progesterone in the different scenarios an embryo transfer can be performed, such as the stimulated cycle, the artificial cycle, or the natural cycle. Although there is no evidence of the perfect protocol for all patients, recent studies point to the need of individualizing luteal phase support according to the needs of each patient.

Datos de la publicación

ISSN/ISSNe:
1521-6934, 1532-1932

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY  ELSEVIER SCI LTD

Tipo:
Article
Páginas:
74-84
PubMed:
32616441
Factor de Impacto:
1,622 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 46

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Assisted reproductive technology, Live birth, Luteal phase support, Pregnancy, Progesterone

Campos de Estudio

Cita

Compartir